Live tape
Thermo FisherNeo Ivy Capital Management Buys 3,865 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeatIlluminaNeo Ivy Capital Management Invests $1.83 Million in Illumina, Inc. $ILMN - MarketBeatEndpoints NewsUniQure’s dispute with FDA; Zealand’s obesity readout; China takes on world’s most expensive medicines; and moreWatersRep. Kevin Hern Shares of Waters Corporation (NYSE:WAT) - MarketBeatLonza NewsLonza sells off its capsules division to British firm - SWI swissinfo.chThermo FisherRally Mode: How Thermo Fisher Scientific Inc. stock reacts to Fed rate cuts - July 2025 Final Week & AI Driven Stock Reports - Naître et grandirIlluminaIllumina Regeneron Alliance Targets Multiomics And Raises Valuation Questions - Yahoo Finance UKWatersKevin Hern acquires Waters Corporation stock through Hern Family Revocable Trust - Investing.com South AfricaAgilentAgilent Technologies (A) Announces Retirement of Key Executive - GuruFocusFierceBiotechFDA’s Vinay Prasad to depart agency at the end of April10x Genomics BlogLife Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers - Yahoo Finance UK10x Genomics BlogLife Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers - Yahoo Finance Australia
Archive

A tighter archive for life-science signals.

Search once, then narrow by source or topic.

Latest first Oldest first Clear filters
Active topic #Medicine
All stories 9
Active topic Medicine
Active query --
FierceBiotech Nov 25, 2025

<a href="https://www.fiercebiotech.com/biotech/sarepta-shares-positive-safety-update-dm1-asset-arrowhead-hits-200m-milestone" hreflang="en">Sarepta shares positive safety update on DM1 asset as Arrowhead snares $200M milestone</a>

A drug safety group has delivered a positive analysis for a Sarepta-licensed RNA medicine, with the same study also hitting an enrollment target. The latter development...

#Sarepta-licensed RNA #RNA medicine #Sarepta shares #enrollment target
Directory ribbon

Brand directory, kept in view

A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.

Open about page